Related Experiment Videos
The Czech Bone Marrow Donor Registry
L Kupková1, N Bendukidze, A Slavcev
1Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. liku@medicon.cz
Insights
The Czech Bone Marrow Donor Registry (CBMD) facilitates international bone marrow transplantation by maintaining a database of HLA-typed donors. This integration allows global access to unrelated stem cells for patients worldwide.
Area of Science:
- Immunology
- Hematology
- Transplantation Medicine
Background:
- The Czech Bone Marrow Donor Registry (CBMD) was established 9 years ago and operates within the National HLA Centre.
- The Czech Cord Blood Register (CSCB) was established in 1996.
Purpose of the Study:
- To describe the operational framework and international integration of the Czech Bone Marrow Donor Registry.
- To highlight the registry's role in facilitating global stem cell transplantation.
Main Methods:
- Maintaining a database of HLA-typed volunteer bone marrow donors.
- Performing national and international searches for bone marrow transplantation.
- Coordinating communication between participating centers.
Main Results:
- The CBMD utilizes modern communication technology for data exchange with national and international organizations.
- The registry is integrated with international networks like BMDW, NMDP, E.D.S., and EMDIS.
- HLA-typed unrelated stem cells from Prague are accessible for patients globally.
Conclusions:
- The CBMD is fully integrated into international cooperation for stem cell donation.
- This integration enables global selection of HLA-typed unrelated stem cells for patients.
Objective:
The Czech Bone Marrow Donor Registry (CBMD)--established 9 years ago, operates within the National HLA Centre, a constituent part of the Department of Immunology at the Institute for Clinical and Experimental Medicine. The Czech Cord Blood Register (CSCB) was recently established (in 1996) and started its activities.
Methods:
CBMD is responsible for maintaining a database of HLA typed volunteer donors, for performing national and international searches in the file of bone marrow transplantation as well as for coordinating the communication between participating centres.
Results:
The operation of the CBMD registry requires the modern communication technology for the exchange of data with local organisations (donor and transplant centres) and with international BM organisations and networks abroad (Bone Marrow Donors Worldwide--BMDW, National Marrow Donor Program--NMDP, European Donor Secretariat E.D.S., European Marrow Donor Information System--EMDIS).
Conclusions:
The CBMD is fully integrated into international cooperation. The HLA typed unrelated stem cells from Prague can be selected for patients in the whole world.